| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/18/2008 | EP1933150A1 Methods of screening of PP1-interacting polypeptides or proteins, peptides inhibiting PP1c binding to Bcl-2 proteins, BCL-XL and BCL-W, and uses thereof |
| 06/18/2008 | EP1932926A2 Method of diagnosing ovarian endometriosis |
| 06/18/2008 | EP1932914A2 Caspase-9 deficient animals and the use thereof |
| 06/18/2008 | EP1932856A2 IL-8 inhibitors |
| 06/18/2008 | EP1932853A1 Novel depsipeptides and process for preparing same |
| 06/18/2008 | EP1932852A1 Novel taxane related peptides and uses thereof |
| 06/18/2008 | EP1932544A1 Gene transfer for treating a connective tissue of a mammalian host |
| 06/18/2008 | EP1932543A2 Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue |
| 06/18/2008 | EP1932539A2 Signal-1/Signal-2 bifunctional peptide inhibitors |
| 06/18/2008 | EP1932536A2 Tissue fusion method using collagenase for repair of soft tissue |
| 06/18/2008 | EP1932535A2 Stimulation of beta cell profileration |
| 06/18/2008 | EP1932534A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 06/18/2008 | EP1932533A1 Composition for amelioration of body lipid |
| 06/18/2008 | EP1932524A1 Pharmaceutical preparations for treating inflammatory diseases |
| 06/18/2008 | EP1931804A2 Combination therapy using budesonide and antisense oligonucleotide targeted to il4-receptor alpha |
| 06/18/2008 | EP1931783A1 Chimeric hcn channels |
| 06/18/2008 | EP1931779A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 06/18/2008 | EP1931708A1 Il-17c antagonists and methods of using the same |
| 06/18/2008 | EP1931701A1 Agent and compositions comprising the same for inhibiting lipases and/or phospholipases in body fluids, cells and tissues |
| 06/18/2008 | EP1931699A2 Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family |
| 06/18/2008 | EP1931697A2 Il-17a and il-17f antagonists and methods of using the same |
| 06/18/2008 | EP1931696A1 ARYIiALKYL AND HETEROARYLALKYL DERIVATIVES OF CYCLOSPORINE A FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION |
| 06/18/2008 | EP1931695A1 Prion-specific peptoid reagents |
| 06/18/2008 | EP1931656A1 Novel drugs for dementia |
| 06/18/2008 | EP1931377A1 Cd4+ t survivin epitopes and uses thereof |
| 06/18/2008 | EP1931374A2 Pth formulations and methods of use |
| 06/18/2008 | EP1931373A2 Treatment of wounds using il-17b |
| 06/18/2008 | EP1931372A1 Method of treating myasthenia gravis |
| 06/18/2008 | EP1931371A1 Peptides capable of modulating the function of tirc7 |
| 06/18/2008 | EP1931370A1 Use of des-aspartate-angiotensin i |
| 06/18/2008 | EP1931369A2 Methods for reducing cd36 expression |
| 06/18/2008 | EP1931368A2 Antifungal peptides and methods of use thereof |
| 06/18/2008 | EP1931353A2 Osteogenic and anti-adiogenic oxysterols |
| 06/18/2008 | EP1931317A2 Pancreatin micropellet cores suitable for enteric coating |
| 06/18/2008 | EP1931316A2 Controlled release pharmaceutical compositions for acid labile drugs |
| 06/18/2008 | EP1931311A1 Polysaccharide microparticles containing biological agents: there preparation and applications |
| 06/18/2008 | EP1931306A1 Non-protein stabilized clostridial toxin pharmaceutical compositions |
| 06/18/2008 | EP1931205A2 Transglutaminase inhibitors and methods of use thereof |
| 06/18/2008 | EP1835927A4 Modified beta thymosin peptides |
| 06/18/2008 | EP1622936B1 Method for the production of an n-terminally modified chemotactic factor |
| 06/18/2008 | EP1496879A4 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2 |
| 06/18/2008 | EP1418922B1 Use of negatively charched phospholipids for the preparation of a medicament for treatment and/or prevention of macular degeneration |
| 06/18/2008 | EP1343895B1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/18/2008 | EP1259269B1 Agent for the treatment of wounds |
| 06/18/2008 | EP1257648B1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 06/18/2008 | EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 06/18/2008 | EP1198479B1 Neovascular-targeted immunoconjugates |
| 06/18/2008 | EP1129106B1 Cyclised conotoxin peptides |
| 06/18/2008 | EP1064027B1 Apo-2 ligand-anti-her-2 antibody synergism |
| 06/18/2008 | EP0914829B1 Preventives and/or remedies for multiple organ failure |
| 06/18/2008 | EP0840617B1 Use of naip or iap for the treatment and prevention of neuronal disease |
| 06/18/2008 | CN101203604A Oas1基因中的突变 Oas1 gene mutation |
| 06/18/2008 | CN101203531A Modified PYY (3-36) peptides and their effects on feeding behaviour |
| 06/18/2008 | CN101203527A Backbone cyclized melanocortin stimulating hormone (alpha MSH) analogs |
| 06/18/2008 | CN101203251A 玻璃体可视化剂 Vitreous visualization agent |
| 06/18/2008 | CN101203238A Proteases for pharmaceutical use |
| 06/18/2008 | CN101203237A Use of interferon gamma for treatment of interleukin-10 deficiency |
| 06/18/2008 | CN101203236A Prophylactic or therapeutic agent for conrneal/conjunctival disease |
| 06/18/2008 | CN101203235A Stable pharmaceutical compositions including motilin-like peptides |
| 06/18/2008 | CN101203234A Milk fat globule epidermal growth factor VIII and sepsis |
| 06/18/2008 | CN101203233A N-acetylcysteine amide (NAC amide) for treatment of oxidative stress associated with infertility |
| 06/18/2008 | CN101200730A IL-12 expression carrier as well as eukaryotic cell strain expressed thereby and uses thereof |
| 06/18/2008 | CN101200720A Mitochondrial membrane potential decrease related polynucleotide as well as coded polypeptide and uses thereof |
| 06/18/2008 | CN101200501A Technique for modifying human cord blood hemoglobin alpha-chain by bis(3,5-dibromo salicyl) fumaric acid esters |
| 06/18/2008 | CN101200493A (3S)-N-(L-aminoacyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, preparation method and uses thereof |
| 06/18/2008 | CN101199842A Lactase sheet and preparing method thereof |
| 06/18/2008 | CN101199841A Lactase capsule and preparing method thereof |
| 06/18/2008 | CN101199840A Lactase chew slice and preparing method thereof |
| 06/18/2008 | CN101199839A Lactase effervescent tablets and preparing method thereof |
| 06/18/2008 | CN101199838A Lactase powders and preparing method thereof |
| 06/18/2008 | CN101199837A Humanized cell factor hair agent and preparing method thereof |
| 06/18/2008 | CN101199836A Stage releasing CsA solid tiny milk agent and tiny milk curing method thereof |
| 06/18/2008 | CN101199497A Polypeptide protein class-medicament under-tongue instant nanometer emulsion and 3D printing preparing method thereof |
| 06/18/2008 | CN101199484A CTLA4-Ig fusion protein preparation |
| 06/18/2008 | CN101199482A Process for preparing degradable polyester microsphere wrapping |
| 06/18/2008 | CN100395339C Method for expressing hepatitis C virus envelope protein E2 by mammal cell with high efficient secretion |
| 06/18/2008 | CN100395331C High purity venom kininogenase prepartion method and its pharmaceutical formulation |
| 06/18/2008 | CN100394981C Human granulocyte-macrophage colony stimulating factor spray and its preparation process |
| 06/17/2008 | US7388124 Adjustment, compression of nervous systems; detection, monitoring variations in pain |
| 06/17/2008 | US7388089 Anti-arthropod vector vaccines method of selecting and uses thereof |
| 06/17/2008 | US7388088 isolated nucleic acid encoding a human antibody that specifically binds to C-ERBB-2 protein product of HER2/NEU oncogene; for diagnosis of cancer/tumors which over express this gene; for immunotoxins and other antitumor/anticarcinogenic agents; less immunogenic |
| 06/17/2008 | US7388086 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7388076 Human immunosuppressive protein |
| 06/17/2008 | US7388075 Medicament containing activated antithrombin III |
| 06/17/2008 | US7388074 Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof |
| 06/17/2008 | US7388072 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA) |
| 06/17/2008 | US7388071 Telomerase peptide is modified to enhance binding to a major histocompatibility complex (MHC) molecule |
| 06/17/2008 | US7388032 Sustained release compositions, process for producing the same and utilization thereof |
| 06/17/2008 | US7388017 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 06/17/2008 | US7388002 Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
| 06/17/2008 | US7387998 STQ peptides |
| 06/17/2008 | US7387997 analogs of alpha -Conotoxin MII that are selective for alpha 6-containing nicotinic acetylcholine receptors; useful for the treatment of disorders involving ion channels, ligand-gated channels, or receptors; inhibiting pain |
| 06/17/2008 | US7387996 Stable insulin formulations prepared by mixing a monomeric insulin and a soluble acylated insulin analog; especially suited for use in an infusion system; superior long-term physical stability |
| 06/17/2008 | US7387995 Method for attaching two surfaces to each other using a bioadhesive polyphenolic protein and periodate ions |
| 06/17/2008 | US7387994 Antitumor, anticancer agents; particles or coils or stents coated solid-phase agent comprising a binding agent comprising collagen are directed to target vasculature, such as the vasculature of solid tumor masses or aneurysms |
| 06/17/2008 | US7387993 Antiinflammatory agents, therapy for infections |
| 06/17/2008 | US7387888 Coronamycins |
| 06/17/2008 | US7387885 polypeptides, multimeric proteins, and polynucleotides of which are for study and regulation of cell and tissue development |
| 06/17/2008 | US7387879 Diagnosis of tauopathies |